T F GALLAGHER - JoVE Visualize

Showing results (41-50 of 52) with videos related to

Pageof 6

Sort By:

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 15, 2004

Determination of insulin requirements: excessive insulin dosages common in type 1 diabetes mellitusJ Akhter, P Struebing, J L Larsen, et al.

FEBS Letters|May 8, 1995

SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1A Cuenda, J Rouse, Y N Doza, et al.

Journal of Nutritional Science and Vitaminology|June 1, 1989

Vitamin supplements and purported learning enhancement in mentally retarded childrenF J Menolascino, J Y Donaldson, T F Gallagher, et al.

Bioorganic & Medicinal Chemistry Letters|October 13, 2001

Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activityJ L Adams, J C Boehm, T F Gallagher, et al.

Radiation Medicine|January 1, 1986

A new method for treatment of unresectable, recurrent brain tumors with single permanent high-activity 125iodine brachytherapyP P Kumar, R R Good, E O Jones, et al.

Bioorganic & Medicinal Chemistry Letters|January 5, 1999

Pyrimidinylimidazole inhibitors of CSBP/p38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymesJ L Adams, J C Boehm, S Kassis, et al.

Transplantation|May 1, 1993

Recipient selection and evaluation for vascularized pancreas transplantationR J Stratta, R J Taylor, T O Wahl, et al.

The Nebraska Medical Journal|December 1, 1991

Combined pancreas--kidney transplantation in NebraskaR J Stratta, R J Taylor, B H Zorn, et al.

The Journal of Biological Chemistry|May 2, 1997

Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP siteP R Young, M M McLaughlin, S Kumar, et al.

Journal of Medicinal Chemistry|September 27, 1996

1-substituted 4-aryl-5-pyridinylimidazoles: a new class of cytokine suppressive drugs with low 5-lipoxygenase and cyclooxygenase inhibitory potencyJ C Boehm, J M Smietana, M E Sorenson, et al.

Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:

Pageof 6

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 15, 2004

Determination of insulin requirements: excessive insulin dosages common in type 1 diabetes mellitusJ Akhter, P Struebing, J L Larsen, et al.

FEBS Letters|May 8, 1995

SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1A Cuenda, J Rouse, Y N Doza, et al.

Journal of Nutritional Science and Vitaminology|June 1, 1989

Vitamin supplements and purported learning enhancement in mentally retarded childrenF J Menolascino, J Y Donaldson, T F Gallagher, et al.

Bioorganic & Medicinal Chemistry Letters|October 13, 2001

Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activityJ L Adams, J C Boehm, T F Gallagher, et al.

Radiation Medicine|January 1, 1986

A new method for treatment of unresectable, recurrent brain tumors with single permanent high-activity 125iodine brachytherapyP P Kumar, R R Good, E O Jones, et al.

Bioorganic & Medicinal Chemistry Letters|January 5, 1999

Pyrimidinylimidazole inhibitors of CSBP/p38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymesJ L Adams, J C Boehm, S Kassis, et al.

Transplantation|May 1, 1993